NRC
National Research Corp
NASDAQ: NRC · HEALTHCARE · HEALTH INFORMATION SERVICES
$16.46
-0.48% today
Updated 2026-04-30
Market cap
$389.19M
P/E ratio
34.22
P/S ratio
2.83x
EPS (TTM)
$0.50
Dividend yield
3.02%
52W range
$11 – $23
Volume
0.1M
National Research Corp (NRC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
8.44%
Operating margin
32.20%
ROE
51.20%
ROA
13.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $43.77M | $5.88M | 55.57% | 22.64% | 13.44% |
| 2007 | $48.92M | $6.84M | 55.44% | 23.23% | 13.98% |
| 2008 | $51.01M | $7.45M | 53.72% | 23.50% | 14.59% |
| 2009 | $57.69M | $8.49M | 57.40% | 23.74% | 14.72% |
| 2010 | $63.40M | $8.50M | 61.14% | 21.86% | 13.41% |
| 2011 | $75.77M | $11.56M | 62.16% | 24.73% | 15.26% |
| 2012 | $86.42M | $15.07M | 58.97% | 26.29% | 17.44% |
| 2013 | $92.59M | $15.48M | 58.05% | 26.79% | 16.72% |
| 2014 | $98.84M | $18.16M | 57.79% | 28.63% | 18.37% |
| 2015 | $102.34M | $17.61M | 56.41% | 25.84% | 17.21% |
| 2016 | $109.38M | $20.52M | 58.33% | 28.52% | 18.76% |
| 2017 | $117.56M | $22.94M | 58.26% | 29.11% | 19.52% |
| 2018 | $119.69M | $30.05M | 60.25% | 29.47% | 25.10% |
| 2019 | $127.98M | $32.41M | 63.72% | 33.63% | 25.32% |
| 2020 | $133.28M | $37.26M | 63.09% | 32.02% | 27.96% |
| 2021 | $147.95M | $37.47M | 64.62% | 33.98% | 25.32% |
| 2022 | $151.57M | $31.80M | 62.36% | 30.71% | 20.98% |
| 2023 | $148.58M | $30.97M | 62.30% | 26.95% | 20.84% |
| 2024 | $143.06M | $24.78M | 60.20% | 24.60% | 17.32% |
| 2025 | $137.39M | $11.60M | 56.33% | 16.44% | 8.44% |